Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Dark-Colored Urine Following Iron Sucrose Infusion

Known Adverse Effects of Iron Sucrose

  • Iron sucrose has a well-established safety profile with relatively few serious adverse effects compared to other intravenous iron preparations, according to the National Kidney Foundation 1, 2
  • Common adverse effects include hypotension and flushing (rare), abdominal cramps (rare, particularly when co-administered with ACE inhibitors), and arthralgias and myalgias (acute rather than delayed), as reported by the American Journal of Kidney Diseases 1, 2
  • The American College of Physicians recommends monitoring for these adverse effects, and notes that no reports of dark-colored urine are mentioned in the clinical practice guidelines for anemia management in chronic kidney disease patients receiving iron sucrose 1, 2

Differential Considerations for Dark Urine

  • Underlying kidney disease may cause urine color changes in patients receiving iron therapy, as noted by the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 3
  • Medication interactions might interact with iron sucrose or independently cause urine discoloration, according to the American College of Clinical Pharmacy 2
  • Dehydration may cause concentrated urine that appears darker, as reported by the European Society of Gastrointestinal Endoscopy 4

Clinical Approach to Dark Urine After Iron Infusion

  • Evaluate kidney function (creatinine, BUN) to assess for underlying kidney disease, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 3
  • Review medication list for other potential causes of urine discoloration, as suggested by the American Society of Health-System Pharmacists 4
  • Ensure adequate hydration status to prevent concentrated urine, as advised by the European Society of Clinical Nutrition and Metabolism 4

Monitoring Recommendations

  • Monitor vital signs during and after infusion, as recommended by the American Society of Anesthesiologists 4
  • Follow hemoglobin, ferritin, and transferrin saturation levels to assess response to therapy, as suggested by the National Comprehensive Cancer Network 4